Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13D/A for Lyra Therapeutics, Inc. Common Stock, $0.001 par value (LYRA).
- Disclosed ownership: 7.8%.
- Date of event: 11 Nov 2025.
PERCEPTIVE ADVISORS LLC - 11 Nov 2025 SCHEDULE 13D/A Report for Lyra Therapeutics, Inc. Common Stock, $0.001 par value (LYRA)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- LYRA
- Shares outstanding
- 1,780,577 shares
- Disclosed Ownership
- 138,885 shares
- Ownership
- 7.8%
- Form type
- SCHEDULE 13D/A
- Filing time
- 13 Nov 2025, 17:05:54 UTC
- Date of event
- 11 Nov 2025
- Previous filing
- 10 Nov 2025
- Next filing
- 18 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 7.8% ownership in Lyra Therapeutics, Inc. Common Stock, $0.001 par value (LYRA) on 11 Nov 2025."
What Changed
- Previous schedule filing date: 10 Nov 2025.
- Current filing was accepted on 13 Nov 2025, 17:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 7.8% | 138,885 | 0 | 138,885 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | 0001224962 |
| Joseph Edelman | 7.8% | 138,885 | 0 | 138,885 | /s/ Joseph Edelman | Joseph Edelman | 0001164426 |
| Perceptive Life Sciences Master Fund, Ltd. | 7% | 124,859 | 0 | 124,859 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | 0001249675 |
| Perceptive LS (A), LLC | 0.8% | 14,026 | 0 | 14,026 | Perceptive LS GP, LLC | Joseph Edelman, Member | 0001797811 |